- Early StageStartup in initial stages
Nostos Genomics Funding
$5M
11 round
Nostos Genomics is active in the following markets / industries: biotechnology, synthetic biology, bioinformatics, artificial intelligence and genetic testing. The company has secured funding across 1 rounds, totaling in an amount of $5M. Their most recent funding was raised on February 4, 2022.
Funding Rounds
Investors of Nostos Genomics
Acequia Capital
Global venture fund investing in early stage technology companies
Rounds
S
Konstantin Mehl
Founder & CEO Kaia Health (www.kaiahealth.com)
Founder & CEO Foodora (www.foodora.com)
Rounds
S
Frontline Ventures
Seed-stage B2B fund in London and Dublin
Rounds
S
42CAP
Rounds
S
Elias Sprengel
Technical co-founder of Audatic.ai. Building systems to make audio better with neural networks.
Charlie Songhurst
Investor
We bring ambitious founders together to build globally important technology companies
Rounds
S
Elgar Fleisch
Worked at @ETH Zurich • Studied at @Vienna University
Cynthia Jurytko
Family Office Venture Capital and Angel Investor with interest in purpose-driven software companies in health, AI and climate tech.
